(Q38141711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Noninvasive evaluation of NAFLD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Valérie Vilgrain

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Paul Angulo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

24 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

666-675

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.175

22 February 2020

exact match

0 references

cites work

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Non-invasive assessment of liver fibrosis: are we ready?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Fatty liver: imaging patterns and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Simple proton spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

A simple index of lipid overaccumulation is a good marker of liver steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Non-invasive evaluation of liver fibrosis using transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Noninvasive methods to assess liver disease in patients with hepatitis B or C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Feasibility of liver transient elastography with FibroScan using a new probe for obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Acute viral hepatitis increases liver stiffness values measured by transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Update on ultrasound imaging of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Magnetic resonance elastography by direct visualization of propagating acoustic strain waves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver pathology and the metabolic syndrome X in severe obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

A position statement on NAFLD/NASH based on the EASL 2009 special conference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Final results of a long-term, clinical follow-up in fatty liver patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Which clinical and sonographic parameters may be useful to discriminate NASH from steatosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver stiffness is directly influenced by central venous pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Serum YKL-40 is increased in patients with hepatic fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Transient elastography in nonalcoholic fatty liver disease: making sense of echoes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.175

Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

12 December 2020

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

1 reference

12 December 2020

Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis

1 reference

12 December 2020

APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

1 reference

12 December 2020

Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations

1 reference

12 December 2020

10.1038/NRGASTRO.2013.175

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061203%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference